Comparison · not a ranking
Cagrilintide compared with Tirzepatide
Cagrilintide and Tirzepatide are separate catalogue items. They are not interchangeable.A CoA for every lot; each vial carries a printed lot number that matches it. Request yours and we email it within 2 hours. Research use only. Not a medicine.
Last verified 9 Nov 2026. UK prices checked daily.
Cagrilintide and Tirzepatide are two distinct catalogue compounds. Cagrilintide is a peptide (lipidated), while Tirzepatide is a 39-residue peptide (lipidated). Cagrilintide: C194H312N54O59S2, 4409.0 g/mol, CAS 1415456-99-3. Tirzepatide: C225H348N48O68, 4813.0 g/mol, CAS 2023788-19-2. In short, their molecular weights differ by about 404.0 g/mol; only Cagrilintide contains sulfur. Each has its own reference record, which lists the source for every figure above. Sable Peptides, a UK supplier operating since 2019, lists both as lyophilised research material; every vial carries a lot number and a certificate of analysis exists for every lot — request yours at /coa-request and we email it within 2 hours. This intro compares identity only and ranks neither compound. Research use only. Not a medicine. Not for human or veterinary use.
Sources: pubchem.ncbi.nlm.nih.gov · pubchem.ncbi.nlm.nih.gov
Cagrilintide and Tirzepatide are two records in the Sable Peptides catalogue at https://www.sablepeptides.co.uk/versus/cagrilintide/tirzepatide. These prices are both Sable catalogue prices. They are not a comparison with another shop. This page does not rank either compound. Each page shows the catalogue price. A market comparison appears only when an exact, current, approved listing for that size is on record. Only a row with the same amount is a like-for-like price.
Research use only. Not a medicine. Not for human or veterinary use. Disclaimer
| Amount | Cagrilintide | Tirzepatide |
|---|---|---|
| 5 mg | £28.00 | £48.49 |
| 10 mg | £39.00 | £30.00 |
Reference facts
| Fact | Cagrilintide | Tirzepatide |
|---|---|---|
| Molecular weight | 4409.0 g/mol | 4813.0 g/mol |
| Molecular formula | C194H312N54O59S2 | C225H348N48O68 |
| CAS number | 1415456-99-3 | 2023788-19-2 |
| Compound class | peptide (lipidated) | peptide (lipidated) |
Sources: pubchem.ncbi.nlm.nih.gov, pubchem.ncbi.nlm.nih.gov Verified 2026-11-09
- Category
- CagrilintideAnalogues
- TirzepatideAnalogues
- Research use only
- CagrilintideYes
- TirzepatideYes
- Vials
- Cagrilintide3
- Tirzepatide7
- Record
- Cagrilintidecagrilintide
- Tirzepatidetirzepatide
Questions this page answers
- How does Cagrilintide compare with Tirzepatide?
- Same vial amounts are shown side by side with each catalogue price. Different amounts are not treated as the same price. No effect is compared, and another seller is not compared.
- Which is better?
- This page does not say. It does not rank safety, strength, or effect.
- What is the lowest catalogue price per mg for Cagrilintide and Tirzepatide?
- Cagrilintide: £3.90/mg on the 10 mg vial (£39.00). Tirzepatide: £2.02/mg on the 20 mg vial (£40.39). Different compounds; this is a catalogue price fact, not a ranking.
- How many vial sizes are listed for each?
- Cagrilintide: 2 mg, 5 mg, 10 mg. Tirzepatide: 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60 mg.
Both compounds
Related research
In-depth comparison
Sable research note. Updated 2026-10-10. Research use only.
Short answer
Cagrilintide and Tirzepatide are different compounds. Cagrilintide is an acylated amylin analogue; Tirzepatide is an incretin-family peptide (GIP/GLP-1 receptor dual agonist). By PubChem's computed values, Tirzepatide (4813 g/mol) is about 1.1 times the mass of Cagrilintide (4409 g/mol). Sable lists both as freeze-dried research material. Research use only: neither is sold as a medicine, and neither is for use in people or animals.
At a glance
| Cagrilintide | Tirzepatide | |
|---|---|---|
| Class | acylated amylin analogue | incretin-family peptide (GIP/GLP-1 receptor dual agonist) |
| Formula (PubChem) | C194H312N54O59S2 | C225H348N48O68 |
| Molecular weight (PubChem, g/mol) | 4409 | 4813 |
| PubChem CID | 171397054 | 166567236 |
| Sable form | freeze-dried powder | freeze-dried powder |
Structure
Cagrilintide is a long-acting amylin analogue with a disulfide bridge and an N-terminal C20 fatty diacid (19-carboxynonadecanoyl) attached through a gamma-glutamyl linker. PubChem CID 171397054 lists the formula C194H312N54O59S2 and a computed molecular weight of 4409 g/mol (https://pubchem.ncbi.nlm.nih.gov/compound/171397054).
Tirzepatide is a 39-residue acylated peptide based on the GIP sequence, with a C20 fatty diacid side chain. PubChem CID 166567236 lists the formula C225H348N48O68 and a computed molecular weight of 4813 g/mol (https://pubchem.ncbi.nlm.nih.gov/compound/166567236).
Both are peptides, so the meaningful structural differences are sequence, length and modifications rather than chemical category. Differences in residue count, terminal capping (acetylation or amidation), non-natural amino acids and lipid side chains all change molecular weight, solubility and how a compound behaves in an assay. Matching like with like at the structural level is the first step before any comparison of experimental results.
Molecular weight in context
On PubChem's computed figures, Cagrilintide is a large peptide (over 3,000 g/mol) and Tirzepatide is a large peptide (over 3,000 g/mol). The difference is 404.0 g/mol.
Molecular weight matters in practice for three reasons. First, one milligram of a lighter compound contains more molecules than one milligram of a heavier one, so equal milligram amounts are not equal molar amounts. Second, the expected mass is what identity testing checks against: mass spectrometry on a certificate of analysis should report a value consistent with the formula. Third, salt forms (for example acetate or TFA counter-ions) and metal complexes add mass that a free-base figure does not show, so a certificate may legitimately quote a slightly different value from a database entry.
Class and research context
Cagrilintide: described in the literature as a long-acting amylin- and calcitonin-receptor agonist; an investigational substance.
Tirzepatide: a dual GIP/GLP-1 receptor agonist; also the active substance of licensed medicines (Sable does not sell those medicines; this product is not a licensed medicine and not sold as one).
These descriptions summarise how each compound is characterised in the published literature and in chemical databases. They are not claims about effects in people, and Sable gives no administration or medical-use information for either compound. Readers who need mechanism detail should go to the primary sources and the PubChem literature sections linked below.
How to compare them fairly
- Compare identity first: formula, sequence and expected mass, then purity.
- Compare amounts only at the same milligram size, remembering that equal milligrams are not equal moles.
- Ask for the certificate of analysis for the specific batch. At Sable, every vial is released at ≥99% purity by HPLC with identity checked against the expected mass, and certificates are available for every lot.
- Treat a search pairing as a navigation habit, not as evidence that two compounds do the same thing.
Sable listings
Vial sizes as listed on 2026-10-10. Each product page carries the current catalogue details.
Cagrilintide (compound guide: https://www.sablepeptides.co.uk/cagrilintide-uk): - Cagrilintide 2 mg: https://www.sablepeptides.co.uk/product/cagrilintide-2mg - Cagrilintide 5 mg: https://www.sablepeptides.co.uk/product/cagrilintide-5mg - Cagrilintide 10 mg: https://www.sablepeptides.co.uk/product/cagrilintide-10mg
Tirzepatide (compound guide: https://www.sablepeptides.co.uk/tirzepatide-uk): - Tirzepatide 5 mg: https://www.sablepeptides.co.uk/product/tirzepatide-5mg - Tirzepatide 15 mg: https://www.sablepeptides.co.uk/product/tirzepatide-15mg - Tirzepatide 20 mg: https://www.sablepeptides.co.uk/product/tirzepatide-20mg - Tirzepatide 10 mg: https://www.sablepeptides.co.uk/product/tirzepatide-10mg - Tirzepatide 30 mg: https://www.sablepeptides.co.uk/product/tirzepatide-30mg - Tirzepatide 40 mg: https://www.sablepeptides.co.uk/product/tirzepatide-40mg - Tirzepatide 60 mg: https://www.sablepeptides.co.uk/product/tirzepatide-60mg
Peptide vials contain freeze-dried powder only; bacteriostatic water is listed separately. Research use only. Not a medicine. Not for human or veterinary use.
Sources
- PubChem, Cagrilintide: https://pubchem.ncbi.nlm.nih.gov/compound/171397054
- PubChem, Tirzepatide: https://pubchem.ncbi.nlm.nih.gov/compound/166567236
- Sable price index and methodology: https://www.sablepeptides.co.uk/pricing/methodology
- Sable quality and certificate requests: https://www.sablepeptides.co.uk/quality
Comparison questions
What is the difference between Cagrilintide and Tirzepatide?
Cagrilintide and Tirzepatide are different compounds. Cagrilintide is an acylated amylin analogue; Tirzepatide is an incretin-family peptide (GIP/GLP-1 receptor dual agonist). By PubChem's computed values, Tirzepatide (4813 g/mol) is about 1.1 times the mass of Cagrilintide (4409 g/mol). Sable lists both as freeze-dried research material. Research use only: neither is sold as a medicine, and neither is for use in people or animals.
What are the molecular weights of Cagrilintide and Tirzepatide?
Cagrilintide: 4409 g/mol (PubChem CID 171397054); Tirzepatide: 4813 g/mol (PubChem CID 166567236).
Are these sold for use in people?
No. Both are laboratory research material only: not medicines, and not for use in people or animals. No administration or medical-use information is provided.